Rubicon Research IPO, valued at Rs 1,377 crore, opened October 9 and saw 51% subscription on Day 1. Trading at a GMP of Rs 85, the pharma firm’s IPO draws strong retail interest, robust brokerage ratings, and optimism for a successful listing.